Shengguang Zhao

Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)

Chengqiang Li, Shengguang Zhao, Yuyan Zheng et al. · European Journal of Cancer · 2020 · 322 citations

Medicine, Oncology, Pharmacology +13

Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Wei-Xiang Qi, Yi Xiang, Shengguang Zhao et al. · Cancer Immunology Immunotherapy · 2021 · 93 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li et al. · Thoracic Cancer · 2023 · 29 citations · Full text

Medicine, Immunology, Oncology +17

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design

Yuyan Zheng, Chengqiang Li, Bentong Yu et al. · JTCVS Open · 2021 · 28 citations · Full text

Medicine, Oncology, Surgery +17

Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)

Yuqin Cao, Dingpei Han, Su Yang et al. · BMC Cancer · 2022 · 16 citations · Full text

Medicine, Oncology, Surgery +14